Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5126
Natural Health Trends
NHTC
$6.54M
| $7 | ﹤0.01% |
7
-481
| -99% | -$791 |
2026 Q2
1 quarter
|
|
5127
Pulmatrix
PULM
$5.04M
| $7 | ﹤0.01% |
4
-11
| -73% | -$18 |
2026 Q2
1 quarter
|
|
5128
Spero Therapeutics
SPRO
$60M
| $7 | ﹤0.01% |
+6
| New | +$8 |
2026 Q3
0 quarters
|
|
5129
Sportsman's Warehouse
SPWH
$42.7M
| $7 | ﹤0.01% |
+6
| New | +$7 |
2026 Q3
0 quarters
|
|
5130
TELA Bio
TELA
$37M
| $7 | ﹤0.01% |
6
-202
| -97% | -$173 |
2026 Q2
1 quarter
|
|
5131
Tandy Leather Factory
TLF
$16.7M
| $7 | ﹤0.01% |
3
-11
| -79% | -$28 |
2026 Q2
1 quarter
|
|
5132
Trio-Tech International Common Stock
TRT
$48.6M
| $7 | ﹤0.01% |
+1
| New | +$10 |
2026 Q3
0 quarters
|
|
5133
Dogwood Therapeutics
DWTX
$48.9M
| $7 | ﹤0.01% |
5
-152
| -97% | -$274 |
2026 Q2
1 quarter
|
|
5134
Virtuix Holdings Inc
VTIX
$18.3M
| $7 | ﹤0.01% |
+6
| New | +$11 |
2026 Q3
0 quarters
|
|
|
AVAT
5135
Avalanche Treasury Corp
AVAT
$31.1M
| $7 | ﹤0.01% |
+4
| New | +$3 |
2026 Q3
0 quarters
|
|
5136
Aligos Therapeutics
ALGS
$25.4M
| $6 | ﹤0.01% |
+1
| New | +$6 |
2026 Q3
0 quarters
|
|
5137
Anixa Biosciences
ANIX
$110M
| $6 | ﹤0.01% |
2
-215
| -99% | -$692 |
2026 Q2
1 quarter
|
|
5138
BTCS Inc
BTCS
$49.2M
| $6 | ﹤0.01% |
4
-127
| -97% | -$157 |
2025 Q3
4 quarters
|
|
5139
Cardiff Oncology
CRDF
$61.9M
| $6 | ﹤0.01% |
5
-5,402
| -100% | -$5.79K |
2024 Q2
9 quarters
|
|
5140
Genasys
GNSS
$63.8M
| $6 | ﹤0.01% |
4
-307
| -99% | -$501 |
2026 Q2
1 quarter
|
|
5141
Phunware
PHUN
$36.2M
| $6 | ﹤0.01% |
3
-163
| -98% | -$339 |
2026 Q2
1 quarter
|
|
5142
Reading International Class A
RDI
$39.4M
| $6 | ﹤0.01% |
3
-67
| -96% | -$114 |
2026 Q2
1 quarter
|
|
|
LNAI
5143
DELISTED
Lunai Bioworks
LNAI
| $6 | ﹤0.01% |
+4
| New | +$10 |
2026 Q3
0 quarters
|
|
5144
Sachem Capital Corp
SACH
$39.3M
| $6 | ﹤0.01% |
6
-230
| -97% | -$200 |
2026 Q2
1 quarter
|
|
5145
RenX Enterprises
RENX
$3.21M
| $6 | ﹤0.01% |
3
-491
| -99% | -$956 |
2026 Q2
1 quarter
|
|
5146
Stran & Co
SWAG
$23.9M
| $6 | ﹤0.01% |
4
-105
| -96% | -$194 |
2026 Q2
1 quarter
|
|
5147
TherapeuticsMD
TXMD
$20.1M
| $6 | ﹤0.01% |
3
-19
| -86% | -$40 |
2026 Q2
1 quarter
|
|
5148
Airgain
AIRG
$52.9M
| $5 | ﹤0.01% |
1
-207
| -100% | -$1.15K |
2026 Q2
1 quarter
|
|
5149
Aqua Metals
AQMS
$4.45M
| $5 | ﹤0.01% |
+2
| New | +$5 |
2026 Q3
0 quarters
|
|
5150
Ark Restaurants
ARKR
$16.2M
| $5 | ﹤0.01% |
1
-6
| -86% | -$32 |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.